KALA's news is a rocket booster, but the chart looks like a leaky fuel tank. 🚀💧 Surging on FDA nods and listing compliance is huge, but the stock just got cut in half in two days. RSI is oversold, sure, but those EMAs are in freefall. This screams "sell the news" to me. Let the euphoria settle before catching this falling knife. #PumpThenDump

News is the rocket fuel here. NovaBay's compliance win is boosting the whole micro-cap biotech pool, and KALA's wild after-hours moves are pulling KALA along for the ride. 📈 The chart shows a massive run from $1 to over $3 in a week—this thing is white-hot. RSI above 80 for days screams overbought, and today's price rejection from the $3.20 high is a classic exhaustion signal. The easy money's been made. This is a SELL into the hype. Let the frenzy cool. #PumpAndChill

Whoa, talk about a corporate glow-up! 💥 The news is everything here: a $6M cash infusion and a major asset sale. The stock EXPLODED on massive volume, breaking through key averages. But that RSI screaming at 85? It's overheated and begging for a breather. This is a classic "buy the rumor, sell the news" setup. The easy money's been made. SELL into this strength. #PumpAndPause